Pharmafile Logo
Pharmafocus logo
Advanced Search

Abbott

Showing 15 posts of 102 posts found.

Pharma creates non-profit R&D organisation

September 21, 2012
Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …

News
Humira image

Humira powers ahead as Abbott prepares split

July 19, 2012
Sales and Marketing AbbVie, Abbott, Humira, RA

Humira maintained its rapid growth in the second quarter, helping keep Abbott buoyant ahead of its split into two separate …

News
AstraZeneca image

AstraZeneca buys Ardea Biosciences

June 22, 2012
Research and Development, Sales and Marketing Abbott, Ardea Biosciences, AstraZeneca, Bayer, Humira, Takeda

AstraZeneca has completed its acquisition of US firm Ardea Biosciences in a $1.26 billion deal that it hopes will shore …

News

Analysts want AstraZeneca-AbbVie tie-up

June 20, 2012
Sales and Marketing AbbVie, Abbott, AstraZeneca, merger

Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future …

News

Abbott sets out AbbVie stall for shareholders

June 12, 2012
Manufacturing and Production AbbVie, Abbott, CRO, Taylor, manufacturing

Abbott Laboratories has issued the prospectus for its planned separation of its pharmaceutical operations into a standalone company called AbbVie …

News
Depakote image

Abbott pays $1.6 billion to settle Depakote claims

May 8, 2012
Medical Communications, Sales and Marketing AbbVie, Abbott, CIA, Depakote

Abbott will pay $1.6 billion to settle US legal claims over its epilepsy drug Depakote.  The $1.6 billion will settle …

News
NASS website

Abbott launches online tool for ankylosing spondylitis

April 23, 2012
Medical Communications AS, Abbott, NHS, NICE, ankylosing spondylitis

Abbott has launched a new online assessment tool that has the potential to change the landscape of ankylosing spondylitis (AS) …

News

Piramal opens ADC plant in Scotland

April 2, 2012
Manufacturing and Production ADC, Abbott, Piramel

India’s Piramal Healthcare has officially opened a new production unit to make antibody-drug conjugates at its facility in Grangemouth, Scotland. …

News
Abbott image

Abbott selects ‘AbbVie’ as new name for R&D firm

March 21, 2012
Research and Development, Sales and Marketing Abbott

Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …

News
Abbott image

Abbott buys into Galapagos’ RA candidate

February 29, 2012
Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF

Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …

News
Lilly picture

Lilly plans €330m biomanufacturing plant in Ireland

February 28, 2012
Manufacturing and Production Abbott, Ireland, Kinsale, lilly

There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …

News

Abbott slashes 700 jobs

January 31, 2012
Manufacturing and Production, Sales and Marketing Abbott, FDA, manufacturing

Abbott Laboratories has said it will cut 700 jobs across its US and Puerto Rican operations, including hundreds of manufacturing …

News
Abbott image

Abbott strong as it prepares for spin-out

January 26, 2012
Sales and Marketing Abbott, GAAP, Humira

Abbott enjoyed a strong 2011 thanks to Humira and emerging market growth, with overall worldwide sales rising by 4.1 per …

News

Vertex chief to step down; names Jeffrey Leiden as new leader

December 19, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex

Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …

Appointment
Abbott picture

Abbott signs $400 million deal with Reata

December 13, 2011
Research and Development, Sales and Marketing Abbott

Abbott has signed a new deal with inflammatory specialist Reata for its portfolio of early-stage compounds. Abbott and Reata Pharmaceuticals …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026